IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Oral Devices and Cannabinoid Sales Update, page-20

  1. 552 Posts.
    lightbulb Created with Sketch. 620
    The main take from all this, resources, time and energy to be re-directed to business making opportunities. Oil's being one of them and penetration looks good!!!
    "Even though sales of oral devices have decreased, IHL expects its
    current quarter of revenue to be significantly higher than the previous corresponding period due to the
    benefit of markedly increasing sales of cannabinoid products".
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.